Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
CA 2310852 A1 · Owner: University Of Southern California · Inventors: Rodgers, Kathleen E.; Dizerega, Gere S.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention fulfills a need in the art for methods that promote hematopoietic and mesenchymal stem and lineage-specific cell proliferation and differentiation by growth in the presence of angiotensinogen angiotensin I , (AI), AI analogues, AI fragments and analogues thereof angiotensin II (AII), AII analogues, AII fragments and analogues thereof and AII AT2 type 2 receptor agonists.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 24, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 24, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 24, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.